デフォルト表紙
市場調査レポート
商品コード
682079

埋め込み用バイオマテリアル - 世界市場の見通し

Implantable Biomaterials - Global Market Outlook (2017-2026)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 195 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
埋め込み用バイオマテリアル - 世界市場の見通し
出版日: 2018年08月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 195 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の埋め込み用バイオマテリアル市場は、2017年に961億1,000万米ドルと評価され、2017年から2026年にかけては8.2%のCAGRで推移し2026年までに1,954億7,000万米ドル規模の市場に成長することが予測されています。世界的な高齢者人口の増加、疾患罹患率の上昇、移植術の実施件数の増加、移植術の技術的進歩などが当市場の主な成長要因となっています。

当レポートでは、世界の埋め込み用バイオマテリアル市場を調査し、市場の概要、材料・用途・地域別の市場規模の推移と予測、市場動向、市場の成長要因・阻害要因ならびに脅威・市場機会の分析、競合情勢、主要企業の情報など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向分析

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • 脅威
  • 用途分析
  • 新興市場
  • 今後の市場のシナリオ

第4章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係

第5章 世界の埋め込み用バイオマテリアル市場:材料別

  • イントロダクション
  • 天然材料
  • セラミックス
  • ポリマー
  • 金属

第6章 世界の埋め込み用バイオマテリアル市場:用途別

  • イントロダクション
  • 歯科
  • 心臓血管
  • 眼科
  • 整形外科
  • その他

第7章 世界の埋め込み用バイオマテリアル市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第8章 市場の主な動向

  • 合意、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡張
  • その他の主要戦略

第9章 企業プロファイル

  • E. I. DU PONT DE NEMOURS AND COMPANY
  • BASF SE
  • 3M
  • Evonik Industries AG
  • AdvanSource Biomaterials Corporation
  • Royal DSM
  • Corbion Purac
  • Collagen Matrix, Inc.
  • Celanese Corporation
  • Biomet, Inc.
  • Invibio, Inc.
  • Orthofix Holdings, Inc.
  • Stryker Corporation
  • KLS martin and Medtronic.
  • Arthrex
  • Aap Implantate AG
  • Zimmer Biomet Holdings, Inc.
  • CAM Bioceramics BV
図表

List of Tables

  • Table 1 Global Implantable Biomaterials Market Outlook, By Region (2016-2026) ($MN)
  • Table 2 Global Implantable Biomaterials Market Outlook, By Material (2016-2026) ($MN)
  • Table 3 Global Implantable Biomaterials Market Outlook, By Natural (2016-2026) ($MN)
  • Table 4 Global Implantable Biomaterials Market Outlook, By Ceramics (2016-2026) ($MN)
  • Table 5 Global Implantable Biomaterials Market Outlook, By Polymers (2016-2026) ($MN)
  • Table 6 Global Implantable Biomaterials Market Outlook, By Metallic (2016-2026) ($MN)
  • Table 7 Global Implantable Biomaterials Market Outlook, By Application (2016-2026) ($MN)
  • Table 8 Global Implantable Biomaterials Market Outlook, By Dental (2016-2026) ($MN)
  • Table 9 Global Implantable Biomaterials Market Outlook, By Cardiovascular (2016-2026) ($MN)
  • Table 10 Global Implantable Biomaterials Market Outlook, By Ophthalmology (2016-2026) ($MN)
  • Table 11 Global Implantable Biomaterials Market Outlook, By Orthopedic (2016-2026) ($MN)
  • Table 12 Global Implantable Biomaterials Market Outlook, By Other Applications (2016-2026) ($MN)
  • Table 13 North America Implantable Biomaterials Market Outlook, By Country (2016-2026) ($MN)
  • Table 14 North America Implantable Biomaterials Market Outlook, By Material (2016-2026) ($MN)
  • Table 15 North America Implantable Biomaterials Market Outlook, By Natural (2016-2026) ($MN)
  • Table 16 North America Implantable Biomaterials Market Outlook, By Ceramics (2016-2026) ($MN)
  • Table 17 North America Implantable Biomaterials Market Outlook, By Polymers (2016-2026) ($MN)
  • Table 18 North America Implantable Biomaterials Market Outlook, By Metallic (2016-2026) ($MN)
  • Table 19 North America Implantable Biomaterials Market Outlook, By Application (2016-2026) ($MN)
  • Table 20 North America Implantable Biomaterials Market Outlook, By Dental (2016-2026) ($MN)
  • Table 21 North America Implantable Biomaterials Market Outlook, By Cardiovascular (2016-2026) ($MN)
  • Table 22 North America Implantable Biomaterials Market Outlook, By Ophthalmology (2016-2026) ($MN)
  • Table 23 North America Implantable Biomaterials Market Outlook, By Orthopedic (2016-2026) ($MN)
  • Table 24 North America Implantable Biomaterials Market Outlook, By Other Applications (2016-2026) ($MN)
  • Table 25 Europe Implantable Biomaterials Market Outlook, By Country (2016-2026) ($MN)
  • Table 26 Europe Implantable Biomaterials Market Outlook, By Material (2016-2026) ($MN)
  • Table 27 Europe Implantable Biomaterials Market Outlook, By Natural (2016-2026) ($MN)
  • Table 28 Europe Implantable Biomaterials Market Outlook, By Ceramics (2016-2026) ($MN)
  • Table 29 Europe Implantable Biomaterials Market Outlook, By Polymers (2016-2026) ($MN)
  • Table 30 Europe Implantable Biomaterials Market Outlook, By Metallic (2016-2026) ($MN)
  • Table 31 Europe Implantable Biomaterials Market Outlook, By Application (2016-2026) ($MN)
  • Table 32 Europe Implantable Biomaterials Market Outlook, By Dental (2016-2026) ($MN)
  • Table 33 Europe Implantable Biomaterials Market Outlook, By Cardiovascular (2016-2026) ($MN)
  • Table 34 Europe Implantable Biomaterials Market Outlook, By Ophthalmology (2016-2026) ($MN)
  • Table 35 Europe Implantable Biomaterials Market Outlook, By Orthopedic (2016-2026) ($MN)
  • Table 36 Europe Implantable Biomaterials Market Outlook, By Other Applications (2016-2026) ($MN)
  • Table 37 Asia Pacific Implantable Biomaterials Market Outlook, By Country (2016-2026) ($MN)
  • Table 38 Asia Pacific Implantable Biomaterials Market Outlook, By Material (2016-2026) ($MN)
  • Table 39 Asia Pacific Implantable Biomaterials Market Outlook, By Natural (2016-2026) ($MN)
  • Table 40 Asia Pacific Implantable Biomaterials Market Outlook, By Ceramics (2016-2026) ($MN)
  • Table 41 Asia Pacific Implantable Biomaterials Market Outlook, By Polymers (2016-2026) ($MN)
  • Table 42 Asia Pacific Implantable Biomaterials Market Outlook, By Metallic (2016-2026) ($MN)
  • Table 43 Asia Pacific Implantable Biomaterials Market Outlook, By Application (2016-2026) ($MN)
  • Table 44 Asia Pacific Implantable Biomaterials Market Outlook, By Dental (2016-2026) ($MN)
  • Table 45 Asia Pacific Implantable Biomaterials Market Outlook, By Cardiovascular (2016-2026) ($MN)
  • Table 46 Asia Pacific Implantable Biomaterials Market Outlook, By Ophthalmology (2016-2026) ($MN)
  • Table 47 Asia Pacific Implantable Biomaterials Market Outlook, By Orthopedic (2016-2026) ($MN)
  • Table 48 Asia Pacific Implantable Biomaterials Market Outlook, By Other Applications (2016-2026) ($MN)
  • Table 49 South America Implantable Biomaterials Market Outlook, By Country (2016-2026) ($MN)
  • Table 50 South America Implantable Biomaterials Market Outlook, By Material (2016-2026) ($MN)
  • Table 51 South America Implantable Biomaterials Market Outlook, By Natural (2016-2026) ($MN)
  • Table 52 South America Implantable Biomaterials Market Outlook, By Ceramics (2016-2026) ($MN)
  • Table 53 South America Implantable Biomaterials Market Outlook, By Polymers (2016-2026) ($MN)
  • Table 54 South America Implantable Biomaterials Market Outlook, By Metallic (2016-2026) ($MN)
  • Table 55 South America Implantable Biomaterials Market Outlook, By Application (2016-2026) ($MN)
  • Table 56 South America Implantable Biomaterials Market Outlook, By Dental (2016-2026) ($MN)
  • Table 57 South America Implantable Biomaterials Market Outlook, By Cardiovascular (2016-2026) ($MN)
  • Table 58 South America Implantable Biomaterials Market Outlook, By Ophthalmology (2016-2026) ($MN)
  • Table 59 South America Implantable Biomaterials Market Outlook, By Orthopedic (2016-2026) ($MN)
  • Table 60 South America Implantable Biomaterials Market Outlook, By Other Applications (2016-2026) ($MN)
  • Table 61 Middle East & Africa Implantable Biomaterials Market Outlook, By Country (2016-2026) ($MN)
  • Table 62 Middle East & Africa Implantable Biomaterials Market Outlook, By Material (2016-2026) ($MN)
  • Table 63 Middle East & Africa Implantable Biomaterials Market Outlook, By Natural (2016-2026) ($MN)
  • Table 64 Middle East & Africa Implantable Biomaterials Market Outlook, By Ceramics (2016-2026) ($MN)
  • Table 65 Middle East & Africa Implantable Biomaterials Market Outlook, By Polymers (2016-2026) ($MN)
  • Table 66 Middle East & Africa Implantable Biomaterials Market Outlook, By Metallic (2016-2026) ($MN)
  • Table 67 Middle East & Africa Implantable Biomaterials Market Outlook, By Application (2016-2026) ($MN)
  • Table 68 Middle East & Africa Implantable Biomaterials Market Outlook, By Dental (2016-2026) ($MN)
  • Table 69 Middle East & Africa Implantable Biomaterials Market Outlook, By Cardiovascular (2016-2026) ($MN)
  • Table 70 Middle East & Africa Implantable Biomaterials Market Outlook, By Ophthalmology (2016-2026) ($MN)
  • Table 71 Middle East & Africa Implantable Biomaterials Market Outlook, By Orthopedic (2016-2026) ($MN)
  • Table 72 Middle East & Africa Implantable Biomaterials Market Outlook, By Other Applications (2016-2026) ($MN)
目次

According to Stratistics MRC, the Global Implantable Biomaterials market is accounted for $96.11 billion in 2017 and is expected to reach $195.47 billion by 2026 growing at a CAGR of 8.2%. Factors such as growing geriatric inhabitants worldwide, growing incidences of diseases and graft transplant surgeries, medical implants and technological advancements will drive the market growth. However, adverse reactions to biomaterials and strict regulatory requirements are some of the factors hampering the market growth.

A biomaterial is any substance of metallic, polymer, ceramic or natural origin that is suitable for introducing into living tissue as an implant without adversely affecting the patient. The selection of biomaterial is dependent on the application and properties of materials. Biomaterials are used to develop and manufacture implantable medical devices and grafts in many medical conditions.

Based on application, orthopedic segment is projected to grow due to growing degenerative bone diseases like osteoporosis and osteoarthritis, rising demand for minimally invasive surgeries and increase in accidents and sports injuries are factors favouring the market growth. In terms of geography, North America holds the largest market revenue due to rise in new products and the development of new biomaterials for ophthalmology, tissue engineering, plastic surgery and wound healing are fuel the market growth in this region.

Some of the key players in the Implantable Biomaterials market include E. I. DU PONT DE NEMOURS AND COMPANY, BASF SE, 3M , Evonik Industries AG, AdvanSource Biomaterials Corporation, Royal DSM, Corbion Purac, Collagen Matrix, Inc., Celanese Corporation, Biomet, Inc., Invibio, Inc., Orthofix Holdings, Inc., Stryker Corporation, KLS martin and Medtronic, Arthrex, Aap Implantate AG, Zimmer Biomet Holdings, Inc. and CAM Bioceramics BV.

Materials Covered:

  • Natural
  • Ceramics
  • Polymers
  • Metallic

Applications Covered:

  • Dental
  • Cardiovascular
  • Ophthalmology
  • Orthopedic
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Implantable Biomaterials Market, By Material

  • 5.1 Introduction
  • 5.2 Natural
  • 5.3 Ceramics
  • 5.4 Polymers
  • 5.5 Metallic

6 Global Implantable Biomaterials Market, By Application

  • 6.1 Introduction
  • 6.2 Dental
  • 6.3 Cardiovascular
  • 6.4 Ophthalmology
  • 6.5 Orthopedic
  • 6.6 Other Applications

7 Global Implantable Biomaterials Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 E. I. DU PONT DE NEMOURS AND COMPANY
  • 9.2 BASF SE
  • 9.3 3M
  • 9.4 Evonik Industries AG
  • 9.5 AdvanSource Biomaterials Corporation
  • 9.6 Royal DSM
  • 9.7 Corbion Purac
  • 9.8 Collagen Matrix, Inc.
  • 9.9 Celanese Corporation
  • 9.10 Biomet, Inc.
  • 9.11 Invibio, Inc.
  • 9.12 Orthofix Holdings, Inc.
  • 9.13 Stryker Corporation
  • 9.14 KLS martin and Medtronic.
  • 9.15 Arthrex
  • 9.16 Aap Implantate AG
  • 9.17 Zimmer Biomet Holdings, Inc.
  • 9.18 CAM Bioceramics BV